Evidence map›Paper›PMID 28331417›Full record

ArticleYonago acta medica2017

γ-Tocotrienol Inhibits TGF-β1-Induced Contractile Phenotype Expression of Human Airway Smooth Muscle Cells.

Takehito Fukushima, Akira Yamasaki, Tomoya Harada, Hiroki Chikumi, Masanari Watanabe, Ryota Okazaki, Miki Takata, Yasuyuki Hasegawa, Jun Kurai, Masaaki Yanai and 4 more

Open access · greenAbstract read
In one paragraph

Article in Yonago acta medica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. TGF-β1 Evokes Human Airway Smooth Muscle Cell Shortening and Hyperresponsiveness via Smad3.American journal of respiratory cell and molecular biology · 2018
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Takehito FukushimaDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Akira YamasakiDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Tomoya HaradaDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Hiroki ChikumiDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Masanari WatanabeDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Ryota OkazakiDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Miki TakataDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Yasuyuki HasegawaDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Jun KuraiDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Masaaki YanaiDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Akihiro YamamotoDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Yuriko SuedaDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Andrew J Halayko†Departments of Physiology and Pathophysiology, and Internal Medicine, University of Manitoba, Winnipeg, MB R3E 3P4 Canada.
Eiji ShimizuDivision of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Tottori University · JPUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTocotrienols, members of the vitamin E family, exist in four different isoforms (α, β, γ and δ tocotrienol) that have can be protective against brain damage, as well as having anticancer effects

methodsASM cells were stimulated with TGF-β1 (2 ng/mL) for 48 hours and the effect of γ-tocotrienol (50 μM) on α-smooth muscle actin, fibronectin and collagen I expression was assessed using Western blotting. The signaling pathways involved in TGF-β1 stimulation were also investigated.

resultsTGF-β1 increased α-smooth muscle actin, fibronectin and collagen Ⅰ abundance by 3- to 5-fold. This response was inhibited significantly by γ-tocotrienol. Furthermore, γ-tocotrienol suppressed RhoA activation, but did not affect Smad2 or Smad3 phosphorylation.

conclusionThese results indicate that γ-tocotrienol has potential for benefit in modulating on airway remodeling in asthma, likely via a mechanism involving the suppression of TGF-β activation of RhoA.

Indexed as

airway smooth muscleasthmaremodelingvitamin Eγ-Tocotrienol

Identifiers

PMID28331417
PMCPMC5355840
OpenAlexW2946177754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.